Nevertheless, METTL14 has been confirmed to be decreased in bladder cancer, and depletion of Mettl14 accelerated cell proliferation, tumour metastasis and self-renewal by decreasing the stability of m6A-modified Notch1 transcripts (Gu et al., 2019). Here, METTL14 is linked to urinary bladder cancer.